Von Hippel-Lindau syndrome
Information
- Disease name
- Von Hippel-Lindau syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00075348 | Completed | Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome | December 2003 | December 2008 | |
| NCT00089765 | Completed | Phase 1 | Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome | August 10, 2004 | August 15, 2007 |
| NCT01436227 | Completed | Phase 2 | Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome | January 17, 2012 | March 13, 2024 |
| NCT01967537 | Completed | Phase 2 | Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors | October 18, 2013 | March 12, 2018 |
| NCT02859441 | Completed | Phase 1/Phase 2 | A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab | January 23, 2017 | July 9, 2019 |
| NCT01496625 | Recruiting | National Eye Institute Biorepository for Retinal Diseases | June 18, 2012 | ||
| NCT03001349 | Terminated | Early Phase 1 | 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | May 16, 2017 | February 5, 2021 |
| NCT00330564 | Terminated | Phase 2 | Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow | May 2006 | May 2011 |
| NCT00673816 | Terminated | Phase 1/Phase 2 | Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome | May 2008 | February 2011 |
| NCT01266070 | Terminated | Phase 2 | TKI 258 in Von Hippel-Lindau Syndrome (VHL) | November 2012 | December 2015 |